OBJECTIVE: This study aimed to identify factors that predict clearance of high-risk human papillomavirus (HPV) infection and progression to cervical intraepithelial neoplasia (CIN) 2 or higher, in women with normal cervical histology or CIN 1. METHODS: A retrospective analysis was performed on 817 high-risk HPV-infected women with histologically verified CIN 1 or normal cervical histology. Patients were followed-up for a maximum of 24 months. Cervical HPV DNA tests were performed at every visit. RESULTS: At the end of followup, 648/817 (79.3%) patients were free from HPV infection and 66/817 patients (8.1%) progressed to CIN 2 or higher. Age, parity, cytology and viral load at diagnosis were significantly and inversely associated with HPV clearance. Cytology, viral load and presence of CIN 1 lesions were significantly associated with lesion progression. CONCLUSIONS: Cytology and high-risk HPV viral load may be useful markers for the likelihood of high-risk HPV clearance and lesion progression. Histological status, parity and marital status may also be useful factors to consider when predicting progression.
Introduction
Carcinoma of the cervix is the second leading cause of cancer mortality in women worldwide, with approximately half a million new cases occurring annually. 1 The development of cervical cancer is a multistep process that includes a preinvasive precursor stage. 2 Human papillomavirus (HPV) plays a role in the aetiology of cervical cancer. Cervical infection with HPV is usually transient, with 70 -90% of individuals free from virus within 12 -24 months of infection. 3, 4 The majority of persistent infections are caused by high-risk HPV variants such as HPV 31, 33, 45 or 58, 5 and HPV infection precedes the development of low-(LSIL) and high-grade squamous intraepithelial lesions (HSIL). 6 -10 In addition, persistent infection with high-risk HPV is necessary for the development and maintenance of high-grade cervical lesions, and clinical progression is not found in the JW Kim, SH Song, CH Jin et al.
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absence of high-risk HPV. 8 The factors affecting viral persistence versus transient HPV infection are poorly understood.
Most cervical intraepithelial neoplasia (CIN) 1 lesions or HPV infections regress spontaneously if untreated, but some may progress to higher-grade lesions. 11 Several studies have suggested factors (including age, parity, high-risk HPV viral load, marital status, cytology and pathology) that could be used to predict persistence or clearance of HPV infection and progression of CIN 1 lesions, but variable and sometimes controversial results have been reported. 12 -25 Some studies found no correlation between these factors and persistence of HPV infection or risk of development of high-grade lesions. 12, 17, 18, 21, 22, 24, 26 Viral load has been reported to be the main determinant of persistence of infection and development of such lesions, 27 but this issue remains the subject of considerable debate.
The objective of this study was to identify factors that predict clearance of high-risk HPV infection or progression of cervical lesions. 
Patients and methods

STUDY POPULATION
DIAGNOSIS AND CLASSIFICATION OF CERVICAL LESIONS
All patients underwent cervical cytology using a liquid-based cytology imaging system (ThinPrep ® Imaging System; Cytyc Corp., Marlborough, MA, USA). Referrals for colposcopy and colposcopy-directed biopsies were based on the following criteria: (i) Bethesda III System (2001) 28 classification of abnormal Papanicolaou (Pap) smears as (a) atypical squamous cells of undetermined significance (ASC-US), (b) LSIL, (c) atypical squamous cells (cannot exclude HSIL; ASC-H), or (d) HSIL; or (ii) positive HPV test. Colposcopy-directed biopsy results were classified as normal or CIN 1. Patients with histologically confirmed CIN 2 or higher were excluded from the study. All patients were followed-up every 4 or 6 months, according to physician's preference, for a maximum of 24 months or until HPV clearance or diagnosis of CIN 2 or higher (when the natural history of the infection was interrupted by treatment). Follow-up visits included cytological examination of the cervix, HPV test and colposcopic assessment. Colposcopy-directed biopsy of the cervix was performed when lesion progression was suspected. Study outcomes were virus clearance (the absence of HPV DNA by HPV test at any follow-up visit, with no medical or surgical treatment), or lesion progression (from normal/CIN 1 to CIN 2 or higher). The follow-up period was completed in March 2011.
JW Kim, SH Song, CH Jin et al. Factors affecting HPV clearance and CIN progression HPV TESTING
Sampling for HPV DNA was performed with a cervical sampler (Cytobrush Plus ® ; Cooper Surgical, Trumbull, CT, USA). The digene Hybrid Capture 2 (HC-2) High-Risk HPV DNA Test (Qiagen, Venlo, The Netherlands) was used for HPV detection, according to the manufacturer's instructions. This signalamplified hybridization antibody capture assay utilized chemiluminescent detection with a specific probe cocktail for carcinogenic high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68) . A luminometer (Atto Corp., Tokyo, Japan) was used to measure relative light units (RLUs) that indicated the presence or absence of HPV DNA in the specimen. The sample was classified as positive when the RLU/positive control (PC) ratio (RLU of specimen/mean RLU of three PCs) was ≥ 1. When the RLU measurement was less than the cut-off value, the sample was considered to be negative or to have HPV DNA levels below the limit of detection of the assay. RLU/PC ratios also provided an approximation of viral load, which was stratified arbitrarily into three levels: low (≥ 1 -< 10 RLU/PC), intermediate (≥ 10 -< 100 RLU/PC), and high (≥ 100 RLU/PC).
STATISTICAL ANALYSES
Categorical variables were presented as absolute values and percentages. Study participants were categorized by viral clearance or lesion progression. Pearson's χ 2test or Fisher's exact test were used to evaluate the association between clinical and demographic characteristics and clearance or progression. Multiple logistic regression analysis was performed to determine the risk factors for clearance or progression in separate models using age, smoking status, oral contraceptive use, HPV viral load, histological findings from colposcopy-directed biopsies, marital status, parity and cytology (Pap smear) as independent variables. Tests for linear trends were performed by entering the categorical variables as continuous variables in the multiple logistic models. All statistical analyses were performed using SAS ® version 9.2 software (SAS Institute, Cary, NC, USA). A P-value < 0.05 was considered statistically significant.
Results
A total of 817 women with high-risk HPV infection and CIN 1 or normal cervical histology participated in the study. Clinical and demographic characteristics of the study population are given in Table 1 . The median age at diagnosis was 42 years (range 20 -75 years), and the median parity was 2 (range 0 -8). A total of 648/817 (79.3%) patients with high-risk HPV were cleared of infection within 24 months. Of the remaining 169 patients, 66 (39.1%) progressed to CIN 2 or higher (CIN 2, 34 cases; CIN 3, 32 cases).
In univariate analysis, age (P = 0.0009), parity (P = 0.0170), marital status (P = 0.0049), cytology (P = 0.0004) and HPV viral load (P = 0.0002) were significantly associated with HPV clearance (Table 1) . Histological findings from colposcopydirected biopsy, smoking status and oral contraceptive use were not associated with HPV clearance. Table 2 shows the adjusted odds ratios and 95% confidence intervals of high-risk HPV clearance. In multiple logistic regression analysis, there was a significant inverse relationship between HPV clearance and age (P = 0.0066), parity (P = 0.0414), cytology (P = 0.0231) and viral load (P = 0.0079). For marital status, only divorced status was significantly inversely associated with HPV clearance (P = 0.0454). Histological findings, smoking status and oral contraceptive use were not correlated with JW Kim, SH Song, CH Jin et al. Table 3 shows the results for the analysis of factors related to the progression to CIN 2 or higher. In univariate analysis, cytology (P < 0.0001), viral load (P < 0.0001) and histological findings on biopsy (P < 0.0001) were significantly associated with progression. Age, parity, marital status, smoking status and oral contraceptive use were not associated with progression. Multiple logistic regression analyses demonstrated that cytology and viral load had a significant linear relationship with the progression to CIN 2 or higher. Women with histologically confirmed CIN 1 had an increased risk of progression, compared with women whose biopsy findings were normal. There was no overall difference in progression according to parity, but parity ≥ 4 was associated with a higher risk of progression compared with nullipara. With regard to marital status, compared with single women, only married status was significantly associated with progression. Age, smoking status and oral contraceptive use were not associated with progression to CIN 2 or higher.
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Discussion
In order to persist, HPV may require the high viral load that results from viral replication. The kinetics of HPV load -rather than a single HPV detection -might be a more reliable indicator of whether HPV infection will persist or be cleared. 29 CIN with high HPV viral load is more likely to persist than CIN with a low level of high-risk HPV DNA, 30 and women with low HPV DNA levels (< 10 pg/ml) are more likely to clear their HPV infections than those with high viral load infections. 23 One study showed a significant difference in the median time to clearance of high-risk HPV infection between women with initial RLU/unit ratio values < 10.0 and ≥ 10.0 (4.5 versus 14.5 months, respectively), suggesting that persistent high-risk HPV infection is associated with a high viral load. 13 In accordance with these findings, the current study found that women with low viral loads had a significantly higher likelihood of clearing high-risk HPV infection than women with intermediate or high viral loads. HPV viral load may act as an early predictor of the risk of developing cervical carcinoma in situ, 31 with evidence of a doseresponse relationship between increasing oncogenic HPV viral load and the risk of LSIL and HSIL. 32 In histological terms, more severe lesions tend to be larger and harbour more HPV viral copies; an upward trend of viral load has been shown to parallel the increase in the risk of the development of large or high-grade lesions. 33 High viral load may also be used as a short-term marker of progression toward precancerous lesions, although a lower viral load does not inevitably exclude progressive disease. 23 A previous study found that women with high viral load had a 13-fold greater chance of progression of untreated mild dysplasia than those with low viral load and a negative HPV test. 19 A high viral load (≥ 100 RLU/PC) was associated with a 2.75-fold greater chance of progression than a low viral load (1 to < 10 RLU/PC) in the current study, but intermediate viral load was not associated with progression. This indicates that progression to CIN 2 or higher might be more related to high viral load than HPV clearance or persistence.
One study found that women with abnormal cytology had an increased risk of persistence of a current carcinogenic HPV infection. 26 Abnormal cytology has been shown to be independently associated with an overall type-specific persistent HPV infection. 14 
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with normal cytology is half that of HPVpositive women with LSIL. 17 Cytology was significantly associated with HPV clearance and progression in the current study. In particular, women with high-grade cytology (ASC-H and HSIL) had a 7.84-fold greater chance of progression than those with normal cytology, suggesting that women with high-grade cytology should be followed cautiously.
Previous studies have revealed no significant difference in histological findings between women with HPV clearance or persistence. 34, 35 These findings are in contrast to those of others who found that the rate of progression to CIN 2 or 3 correlated with the first histological finding, developing in 7.7% of patients with CIN 1 at the first follow-up evaluation compared with 5.0% of patients with normal histological findings. 18 The current study found that women with CIN 1 had a 2.53-fold greater chance of progression than those with normal pathology, but histological findings were not associated with HPV clearance. Women positive for high-risk HPV who are diagnosed with CIN 1 lesions are at risk of progression to higher-grade lesions and should be closely monitored.
Some studies have found that HPV persistence was associated with increased age. 12, 26, 34 The risk of CIN 3 or carcinoma has also been shown to increase with age, 20 but other studies have found no correlation. 17, 18 Age was significantly and inversely associated with high-risk HPV clearance in the present study, but there was no correlation with progression. These contrasting results may be due to the different age ranges included in each study design. The current study included a wide age range and found that women > 60 years old had the lowest HPV clearance, suggesting that they should be followed for a longer period of time than younger women.
Studies have reported variable associations between high parity and HPV persistence, and an increased risk of cervical cancer or CIN. 12, 16, 17, 21, 22, 24, 26, 36 In one study, high-risk HPV clearance was significantly reduced among women with three or more pregnancies, compared with nulliparous women, 16 but other studies reported that multiparity did not influence short-term HPV persistence. 12, 26 High parity was found to modulate the risk of progression from HPV infection or LSIL to HSIL and cervical cancer, 36 suggesting that multiparous women may need close surveillance for cytological abnormalities and HPV infections. Lower parity was associated with disease regression after adjustment for HPV infection. 24 Other studies found no relationship between pregnancy or parity and risk of CIN 2 or CIN 3. 21, 22 Parity was significantly and inversely associated with HPV clearance in the present study, but only women with parity ≥ 4 had an increased risk of progression, with a 6.22-fold greater chance of progression than nulliparous women. The variable findings in these reports may be due to the different parity distributions in each study design. The association between parity and high-grade lesions has several explanations. High concentrations of oestrogen and progesterone during pregnancy and delivery-related cervical trauma cause the eversion of the columnar epithelium onto the ectocervix, which increases the exposure of the squamous-columnal junction to HPV infection. 21 In addition, the immunosuppression caused by pregnancy may also favour the infection and oncogenic potential of HPV.
Reports on the association between marital status and progression to CIN are limited and contradictory, suggesting that marriage is, 25 or is not, 24 
women had lower HPV clearance than single women and married women had a 3.86-fold greater chance of progression than single women. To our knowledge, this finding has not been previously reported. Because the clearance of HPV infection and the progression of cervical lesions is affected by multiple factors, prospective studies including additional factors (such as sexual habits) may be needed to confirm whether marital status is associated with HPV clearance or progression of CIN.
Several factors might have contributed to the differences between current results and those of previous studies, including patient selection criteria, duration of follow-up and analytical methods. The current study selected only patients infected with types of high-risk HPV that were detected using the HC-2 semiquantitative analysis system. HC-2 values can be used as a quantitative measure of high-risk HPV DNA as long as cervical specimens are collected using standardized protocols, 37 such as those used in this study. The duration of follow-up in the present study was 24 months. The majority of HPV infections clear within 2 years, and any persisting infections have a high potential to cause progression to precancer and cancer. 38, 39 The limitations of the current study include its retrospective design and the relatively small sample size in some patient categories (including smoking and oral contraceptive use). Additional studies, involving larger numbers of cases, are required. Despite these limitations, this study contributes to the understanding of the factors associated with the natural course of high-risk HPV clearance and the progression to CIN 2 or higher, which may be useful in the estimation of clearance or progression risk.
In conclusion, the current study demonstrated that age, parity, cytology and high-risk HPV viral load were significantly and inversely associated with high-risk HPV clearance in patients with untreated CIN 1 or normal cervical histology. The study also demonstrated an increased likelihood of progression to CIN 2 or higher among patients with high-grade cytology, high viral load, CIN 1, high parity or married status; these findings suggest that women with these characteristics should be followed closely. In particular, these results suggest that cytology and high-risk HPV viral load may be considered as short-term markers of the likelihood of both clearance of high-risk HPV infection and lesion progression. Histological status, parity and marital status might also be useful factors to consider when predicting the risk of progression.
